ArticleFrontiers in nutrition2025
Global burden of ischemic heart disease attributable to dietary factors: insights from the global burden of disease study 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Per- and Polyfluoroalkyl Substances Exposure and Ischemic Heart Disease: Emerging Evidence from the Literature.Antioxidants (Basel, Switzerland) · 2026Review
- From Exposure to Atherosclerosis: Mechanistic Insights into Phthalate-Driven Ischemic Heart Disease and Prevention Strategies.Life (Basel, Switzerland) · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dietary risk factors remain a leading modifiable contributor to ischemic heart disease (IHD), yet global trends and inequities in diet-attributable IHD burden remain incompletely quantified. This study examines the global, regional, and demographic burden of IHD attributable to dietary risks from 1990 to 2021, and projects future trends through 2050 using data from the Global Burden of Disease (GBD) 2021 study. Methods: GBD 2021 estimates were used to quantify IHD-related deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) attributable to dietary risks across 204 countries and territories. Inequality was assessed using the slope index of inequality (SII) and concentration index (CI). A decomposition analysis evaluated the relative contributions of population growth, aging, and epidemiologic transitions to changes in burden. Future projections were modeled using autoregressive integrated moving average (ARIMA) and exponential smoothing (ES) techniques. Results: In 2021, IHD attributable to dietary risk factors accounted for 3,906,345 deaths, 89,929,809 DALYs, 1,851,908 YLDs, and 88,077,900 YLLs globally. The highest burden was observed in middle socio-demographic index (SDI) regions. The disease burden was markedly higher in males, with deaths and DALYs peaking at ages 60-64 and 65-69 years. Decomposition analysis revealed that population growth drove a 456.03% increase in global deaths, while accelerated aging in high SDI regions disproportionately contributed to YLDs (-161.51%). Declines in inequality indices suggested reductions in mortality, DALYs, YLDs, and YLLs disparities. Forecasts indicated a continued decline in age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), age-standardized YLDs rate (ASYR), and age-standardized YLLs rate. Conclusion: Persistent disparities in diet-related IHD burden are shaped by sociodemographic and sex-specific dynamics. Urgent dietary interventions are needed in low- and lower-middle SDI regions, while high-SDI countries must prioritize disability prevention in aging populations. Stratified, context-specific strategies and strengthened monitoring of health inequalities are essential to reduce global cardiovascular disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.